R. W. Lacey
- Infectious Diseases top 1%
- Molecular Biology top 10%
- Epidemiology top 5%
- Molecular Medicine top 1%
- Clinical Biochemistry top 1%
- Co-authors
- J. GrinstedI. ChopraEvelyn L. LewisS.F. DeallerDavid A. JohnstonS.A. ClaydenM F DixonA T Axon
- Topics
- Antimicrobial Resistance in Staphylococcus (59 papers)Bacterial biofilms and quorum sensing (19 papers)Microbial Metabolism and Applications (16 papers)
- Partner nations
- United KingdomUnited StatesThailand
In The Last Decade
R. W. Lacey
117 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 135
- Infectious Diseases 1.3k
- Molecular Biology 874
- Epidemiology 574
- Molecular Medicine 414
- Clinical Biochemistry 376
Countries citing papers authored by R. W. Lacey
This map shows the geographic impact of R. W. Lacey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. W. Lacey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. W. Lacey more than expected).
Fields of papers citing papers by R. W. Lacey
This network shows the impact of papers produced by R. W. Lacey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. W. Lacey. The network helps show where R. W. Lacey may publish in the future.
Co-authorship network of co-authors of R. W. Lacey
This figure shows the co-authorship network connecting the top 25 collaborators of R. W. Lacey. A scholar is included among the top collaborators of R. W. Lacey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. W. Lacey. R. W. Lacey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 73 | |
| 3 | 12 | |
| 4 | 13 | |
| 5 | 13 | |
| 6 | 9 | |
| 7 | 24 | |
| 8 | 6 | |
| 9 | 8 | |
| 10 | 3 | |
| 11 | 11 | |
| 12 | 50 | |
| 13 | 1 | |
| 14 | 0 | |
| 15 | 16 | |
| 16 | 14 | |
| 17 | 4 | |
| 18 | 27 | |
| 19 | 1 | |
| 20 | 9 |
About R. W. Lacey
R. W. Lacey is a scholar working on Infectious Diseases, Biotechnology and Molecular Medicine, having authored 126 papers that have together received 2.6k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (59 papers), Bacterial biofilms and quorum sensing (19 papers) and Microbial Metabolism and Applications (16 papers). The work is most often cited by research in Molecular Medicine (414 citations), Infectious Diseases (1.3k citations) and Clinical Biochemistry (376 citations). R. W. Lacey has collaborated with scholars based in United Kingdom, United States and Thailand. Frequent co-authors include J. Grinsted, I. Chopra, Evelyn L. Lewis, S.F. Dealler, David A. Johnston, S.A. Clayden, M F Dixon, A T Axon, Vibeke Thamdrup Rosdahl and Dermot Burke. Their work appears in journals such as The Lancet, Applied and Environmental Microbiology and Annals of the New York Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.